These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34851749)

  • 21. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates.
    Nicasio AM; Crandon JL; Nicolau DP
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2756-61. PubMed ID: 19364850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus.
    Hesje CK; Drlica K; Blondeau JM
    J Antimicrob Chemother; 2015 Feb; 70(2):494-7. PubMed ID: 25324419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
    Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
    Ontong JC; Ozioma NF; Voravuthikunchai SP; Chusri S
    PLoS One; 2021; 16(1):e0244673. PubMed ID: 33406110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several β-lactamase and integron genes collected from several hospitals in the north of Iran.
    Farhadi M; Ahanjan M; Goli HR; Haghshenas MR; Gholami M
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):70. PubMed ID: 34583687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.
    Morici P; Florio W; Rizzato C; Ghelardi E; Tavanti A; Rossolini GM; Lupetti A
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1739-1748. PubMed ID: 28470337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Porins and bla
    Balabanian G; Rose M; Manning N; Landman D; Quale J
    Microb Drug Resist; 2018 Sep; 24(7):877-881. PubMed ID: 29782237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
    Tsala M; Vourli S; Georgiou PC; Pournaras S; Daikos GRL; Mouton JW; Meletiadis J
    J Antimicrob Chemother; 2019 Feb; 74(2):387-394. PubMed ID: 30376071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of
    Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
    Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
    Parra Millán R; Jiménez Mejías ME; Sánchez Encinales V; Ayerbe Algaba R; Gutiérrez Valencia A; Pachón Ibáñez ME; Díaz C; Pérez Del Palacio J; López Cortés LF; Pachón J; Smani Y
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4464-70. PubMed ID: 27161639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mutant prevention concentrations of antibacterial agents to ocular pathogenic bacteria].
    Liang QF; Wang ZQ; Li R; Luo SY; Deng SJ; Sun XG
    Zhonghua Yan Ke Za Zhi; 2009 Jan; 45(1):61-5. PubMed ID: 19484933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.
    Fernández-Canigia L; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2012 Oct; 11():29. PubMed ID: 23088592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.